Xcede Technologies, Inc. Joint Venture (Details Textual) - USD ($)

1 Months Ended

3 Months Ended

9 Months Ended

Nov. 30, 2016

Nov. 18, 2016

Jun. 30, 2018

Jun. 30, 2017

Jun. 30, 2018

Jun. 30, 2017

Debt Conversion, Original Debt, Amount

$ 5,500,000

Gain (Loss) on Extinguishment of Debt

$ 1,900,000

Noncontrolling Interest [Member]

Debt Conversion, Original Debt, Amount

$ 3,100,000

Debt Conversion, Converted Instrument, Shares Issued

3,055,551

Gain (Loss) on Extinguishment of Debt

$ 300,000

Xcede Technologies inc [Member]

Debt Instrument, Interest Rate, Stated Percentage

5.00%

Committed Investment In Cash

$ 1,200,000

Debt Conversion, Converted Instrument, Shares Issued

5,394,120

Capital Stock Financing Discount Percentage

20.00%

Noncontrolling Interest, Description

Noncontrolling interest represents the value of the Series A Preferred and common stock not owned by DBM plus 17% of cumulative losses of Xcede based on the 17% common stock ownership held by noncontrolling interests.

Equity Method Investment, Ownership Percentage

63.00%

63.00%

Dynasil Biomedical [Member]

Debt Conversion, Original Debt, Amount

$ 2,400,000

Debt Conversion, Converted Instrument, Shares Issued

2,338,569

Gain (Loss) on Extinguishment of Debt

$ 1,600,000

External Funding [Member] | Convertible Debt [Member]

Debt Conversion, Original Debt, Amount

$ 5,200,000

Secured Promissory Note [Member] | Xcede Technologies inc [Member]

Debt Instrument, Interest Rate, Stated Percentage

2.00%

Expense Recognized In Long Term Contract

$ 8,000

$ 33,000

$ 209,000

$ 238,000

Imputed Interest Rate

5.40%

Secured Debt, Available Amount

$ 1,500,000

Secured Debt, Outstanding Amount

$ 500,000

Series B Preferred Stock [Member]

Preferred Stock, Liquidation Preference Per Share

$ 1.27

$ 1.27

Preferred Stock, Liquidation Preference, Value

$ 1,500,000

$ 1,500,000

Series A Preferred Stock [Member]

Debt Conversion, Converted Instrument, Amount

$ 3,600,000

Preferred Stock, Liquidation Preference Per Share

$ 1.016

$ 1.016

Preferred Stock, Liquidation Preference, Value

$ 5,500,000

$ 5,500,000

Series A Preferred Stock [Member] | Noncontrolling Shareholders [Member]

Preferred Stock, Liquidation Preference, Value

3,100,000

3,100,000

Series A Preferred Stock [Member] | Dynasil Biomedical [Member]

Preferred Stock, Liquidation Preference, Value

$ 2,400,000

$ 2,400,000